Biopharmaceutical Purification
Our apologies.
An error has occurred while submitting. Please try again later.
Thank you!
Your form was submitted successfully.
Biopharmaceutical Innovation. Pure and Simple.
The biopharmaceutical industry is under tremendous pressure to bring new biologic drugs from clinic to market with lower manufacturing costs. 3M scientists and engineers are devoted to increasing the number and availability of new life-saving therapies.
3M solutions work to optimise your processes, applying our biopharma experience, material science and proprietary technologies to help you develop highly effective purification solutions. Our solutions are designed for upstream and downstream processing. These solutions are focused on 3M innovative technologies for the development and manufacturing of recombinant proteins, including mAbs, vaccines, and therapeutic plasma proteins.
Biopharmaceutical Applications
-
At 3M, we're advancing the recombinant protein industry by helping build better, more efficient manufacturing processes. We are developing solutions to simplify the process and to enhance biologic drug recovery that leads to improved process economics.
-
Our products and solutions help design and develop manufacturing processes for recombinant proteins, including mAbs, vaccines and therapeutic plasma proteins. These products are designed for impurity removal in harvest, clarification and downstream polishing, which help maximise upstream and downstream purity, leading to overall process economics.
-
3M has been servicing the blood plasma fractionation industry for more than 30 years. We offer a range of products, including depth filters, chromatography products, and membrane products, all of which are supported by our validation services offerings.
-
3M offers a wide range of adsorptive depth filters and membrane products for application in the chemical pharmaceutical industry. These products may be used for a range of applications including, catalyst removal and recovery, colour removal, particulate filtration and fill-finish.
Our experts will work with you to help find the optimal 3M purification and filtration solution for your application and to test our products within your process. We also provide trial data when we work with you to demonstrate the product in-use.
Industry News
Discover insights from industry leaders on the latest trends in bioprocessing. Learn about innovations for optimisation of continuous manufacturing, changes in manufacturing landscapes from biosimilars, and new emerging markets such as cell and gene therapies.
-
Frost & Sullivan: Key Trends Reshaping The Future of Bio-pharmaceutical Harvest and Clarification -
Frost & Sullivan: Perspective on Next Generation Harvest Techniques -
BioProcess Int'l: Anion-Exchange Chromatographic Clarification: Bringing Simplification, Robustness, and Savings to MAb Purification -
Frost & Sullivan: Perspective on Continuous Processing: Trends, Drivers and Strategies -
Frost & Sullivan: Cell Therapy Biomanufacturing: Trends and Perspectives -
Frost & Sullivan: Commercialization Strategies in Global Biosimilars Industry
Industry Awards
-
3M™ Emphaze™ AEX Hybrid Purifier recognized as global product leader2017 Frost & Sullivan Global Biologics Product Leadership Award. With its next generation technology product, the 3M™ Emphaze™ AEX Hybrid Purifier, 3M demonstrates leadership in meeting specific customer needs.
-
3M™ Emphaze™ AEX Hybrid Purifier recognized at MN Tekne Award2018 Minnesota Tekne Biotech/Pharmaceutical Award. MN Tekne Awards celebrate innovation and pioneering efforts in biotechnology or pharmaceuticals to provide game-changing advancement in the healthcare field.
